{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:54:58Z","timestamp":1791114898526,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,15]]},"DOI":"10.1093\/hmg\/ddu208","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T04:21:16Z","timestamp":1399609276000},"page":"4919-4931","source":"Crossref","is-referenced-by-count":44,"title":["An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2"],"prefix":"10.1093","volume":"23","author":[{"given":"Kameswaran","family":"Ravichandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iram","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Brian","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam E.","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"key\n\t\t\t\t20170522131037_DDU208C1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522131037_DDU208C2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522131037_DDU208C3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ki.1991.80","article-title":"C-myc as an inducer of polycystic kidney disease in transgenic mice","volume":"39","year":"1991","journal-title":"Kidney Int."},{"key":"key\n\t\t\t\t20170522131037_DDU208C4","first-page":"1051","article-title":"Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys","volume":"142","year":"1993","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease","volume":"3","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","article-title":"mTOR signaling in disease","volume":"23","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","year":"2002","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170522131037_DDU208C8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522131037_DDU208C9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","year":"2011","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","year":"2004","journal-title":"Curr. Biol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","article-title":"mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling","volume":"1","year":"2011","journal-title":"Cancer Discov."},{"key":"key\n\t\t\t\t20170522131037_DDU208C12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","year":"2006","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170522131037_DDU208C13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1074\/jbc.M111.304337","article-title":"Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein","volume":"287","year":"2012","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522131037_DDU208C14","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170522131037_DDU208C15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"key\n\t\t\t\t20170522131037_DDU208C17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)","volume":"24","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"key\n\t\t\t\t20170522131037_DDU208C18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease (PKD)","volume":"16","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C19","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"key\n\t\t\t\t20170522131037_DDU208C20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","year":"2010","journal-title":"Kidney Int."},{"key":"key\n\t\t\t\t20170522131037_DDU208C22","first-page":"F236","article-title":"mTORC1\/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease","volume":"300","year":"2011","journal-title":"Am. J. Physiol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"`Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats","volume":"26","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"key\n\t\t\t\t20170522131037_DDU208C24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522131037_DDU208C25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522131037_DDU208C26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","year":"2010","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522131037_DDU208C27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000314380","article-title":"The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease","volume":"33","year":"2010","journal-title":"Kidney Blood Press. Res."},{"key":"key\n\t\t\t\t20170522131037_DDU208C28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","year":"2010","journal-title":"J. Am. Soc. Nephrol"},{"key":"key\n\t\t\t\t20170522131037_DDU208C30","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4161\/cc.8.23.10070","article-title":"Targeting mTOR globally in cancer; thinking beyond rapamycin","volume":"8","year":"2009","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170522131037_DDU208C31","first-page":"e141","article-title":"What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)?","volume":"4","year":"2005","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170522131037_DDU208C32","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.0408518102","article-title":"Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease (PKD)","volume":"102","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170522131037_DDU208C33","first-page":"749","article-title":"Deletion of the caspase-3 gene markedly prolongs survival in the cpk mouse model of polycystic kidney disease (PKD)","volume":"19","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4161\/auto.5.5.8504","article-title":"Rapamycin inhibits mTORC1, but not completely","volume":"5","year":"2009","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20170522131037_DDU208C35","first-page":"e38","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","year":"2009","journal-title":"PLoS Biol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C36","first-page":"47","article-title":"mTOR mediated anti-cancer drug discovery","volume":"6","year":"2011","journal-title":"Drug Discov. Today Ther. Strateg."},{"issue":"Pt 14","key":"key\n\t\t\t\t20170522131037_DDU208C37","first-page":"2309","article-title":"Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis","volume":"120","year":"2007","journal-title":"J. Cell Sci.,"},{"key":"key\n\t\t\t\t20170522131037_DDU208C38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcp.21419","article-title":"The PI 3-kinase and mTOR signaling pathways are important modulators of epithelial tubule formation","volume":"216","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C39","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1152\/ajpcell.00145.2010","article-title":"Branching morphogenesis: Rac signaling \u2018PIX\u2019 tubulogenesis. Focus on \u2018Pak1 regulates branching morphogenesis in 3D MDCK cell culture by a PIX and beta1-integrin-dependent mechanism","volume":"299","year":"2010","journal-title":"Am. J. Physiol Cell Physiol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170522131037_DDU208C41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2008.12.017","article-title":"mTOR complex 2 is required for the development of prostate cancer induced by PTEN loss in mice","volume":"15","year":"2009","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170522131037_DDU208C42","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","article-title":"mTOR complex 2 signaling and functions","volume":"10","year":"2011","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170522131037_DDU208C43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s13238-011-1077-3","article-title":"Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis","volume":"2","year":"2011","journal-title":"Protein Cell"},{"key":"key\n\t\t\t\t20170522131037_DDU208C44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.coph.2011.05.003","article-title":"Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options","volume":"11","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C45","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522131037_DDU208C46","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/emboj.2008.119","article-title":"Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling","volume":"27","year":"2008","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170522131037_DDU208C47","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony","volume":"285","year":"2010","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522131037_DDU208C48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease","volume":"93","year":"1998","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522131037_DDU208C49","doi-asserted-by":"crossref","first-page":"C419","DOI":"10.1152\/ajpcell.00038.2007","article-title":"VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25\/\u2212) mice","volume":"293","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"key\n\t\t\t\t20170522131037_DDU208C50","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1093\/ndt\/gfq195","article-title":"Distinct patterns of kidney and liver cyst growth in Pkd2WS25\/\u2212 mice","volume":"25","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"key\n\t\t\t\t20170522131037_DDU208C51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","year":"2004","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522131037_DDU208C52","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1681\/ASN.2006090994","article-title":"Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease","volume":"18","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C53","doi-asserted-by":"crossref","first-page":"F1089","DOI":"10.1152\/ajprenal.00242.2012","article-title":"Insignificant effect of secretin in rodent models of polycystic kidney and liver disease","volume":"303","year":"2012","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0272-6386(97)90039-1","article-title":"Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats","volume":"29","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"key\n\t\t\t\t20170522131037_DDU208C55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2010.12.008","article-title":"Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways","volume":"654","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C56","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2006111218","article-title":"Identification of a forskolin-like molecule in human renal cysts","volume":"18","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t20170522131037_DDU208C57","doi-asserted-by":"crossref","first-page":"F578","DOI":"10.1152\/ajprenal.00455.2005","article-title":"Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis","volume":"291","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T09:23:34Z","timestamp":1565429014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddu208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":57,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2014,5,8]]},"published-print":{"date-parts":[[2014,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddu208","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,8]]}}}